【摘要】：目的:研究錳對(duì)人群和SH-SY5Y細(xì)胞中PARK2表達(dá)的影響。方法:⑴人群研究:選取鐵冶煉廠的20名工人為對(duì)照組,錳鐵合金冶煉廠的26名工人為錳暴露組。收集工人的血液和唾液,采用原子吸收分光光度法(atomic absorption spectrometry,AAS)測(cè)定錳和鐵(iron,Fe)的濃度;實(shí)時(shí)熒光定量-聚合酶鏈反應(yīng)(RT-PCR)檢測(cè)PARK2 mRNA表達(dá)水平。⑵SH-SY5Y細(xì)胞實(shí)驗(yàn):0、100、300、500μM濃度的MnCl_2染毒SH-SY5Y細(xì)胞24小時(shí)后,用MTT法測(cè)細(xì)胞存活率(線粒體損傷),AAS測(cè)定細(xì)胞內(nèi)錳濃度,高度水溶性四唑鹽(WST-1)法測(cè)定細(xì)胞內(nèi)超氧化物歧化酶(superoxide dismutase,SOD)活力,硫代巴比妥酸法(thibabituric acid,TBA)測(cè)定細(xì)胞內(nèi)丙二醛(malondialdehyde,MDA)含量,反相高效液相(reverse phase high performance liquid chromatography,RP-HPLC)-熒光法測(cè)定細(xì)胞內(nèi)多巴胺(dopamine,DA)含量,RT-PCR檢測(cè)PARK2 mRNA表達(dá)水平,蛋白免疫印跡法(western blot,WB)檢測(cè)Parkin蛋白表達(dá)水平。結(jié)果:⑴人群研究:與對(duì)照組比較,錳暴露組血漿、紅細(xì)胞(red blood cell,RBC)、唾液和累積錳暴露的錳濃度分別高出2.2,2.0,1.7和3.0倍(P0.05),錳暴露組血液中PARK2 mRNA的表達(dá)降低42%(P0.05)。相關(guān)性分析顯示,PARK2mRNA的表達(dá)與血漿、RBC、唾液以及累積錳暴露的錳濃度呈負(fù)相關(guān),r值分別為-0.526(P0.05)、-0.317(P0.05)、-0.652(P0.05)、-0.737(P0.05)。⑵SH-SY5Y細(xì)胞實(shí)驗(yàn):與對(duì)照組比較,MnCl_2濃度為300、500μM時(shí),細(xì)胞存活率降低(P0.05)。與對(duì)照組比較,染錳組細(xì)胞內(nèi)錳濃度增高(P0.05)。與對(duì)照組比較,MnCl_2濃度為300、500μM時(shí),SOD活力和DA含量降低(P0.05),MDA含量升高(P0.05);細(xì)胞PARK2 mRNA表達(dá)和Parkin蛋白表達(dá)降低(P0.05)。相關(guān)性分析顯示,PARK2 mRNA表達(dá)與線粒體損傷、細(xì)胞內(nèi)錳含量、MDA含量呈負(fù)相關(guān),r值分別為-0.902,(P0.05)、-0.880(P0.05)、-0.862(P0.05);PARK2 mRNA表達(dá)與SOD活力、DA含量、Parkin蛋白表達(dá)呈正相關(guān),r值分別為0.879(P0.05)、0.859(P0.05)、0.809(P0.05)。結(jié)論:1錳暴露工人血液中PARK2 mRNA表達(dá)下降,并與血漿、RBC、唾液以及累積錳暴露的錳濃度呈負(fù)相關(guān)。2錳暴露引起SH-SY5Y細(xì)胞線粒體損傷、氧化應(yīng)激、DA分泌減少和PARK2表達(dá)下降。
[Abstract]:Objective: to study the effect of manganese on the expression of PARK2 in human and SH-SY5Y cells. Methods: 1 crowd study: 20 workers in iron smelter were selected as control group and 26 workers in manganese alloy smelter as exposed group. The blood and saliva of the workers were collected and the concentrations of manganese and iron (iron,Fe) were determined by atomic absorption spectrophotometry (atomic absorption spectrometry,AAS). Real-time fluorescence quantification-polymerase chain reaction (RT-PCR) was used to detect the expression of PARK2 mRNA. 2SH-SY5Y cell experiment: after 0100300500 渭 M MnCl_2 was exposed to SH-SY5Y cells for 24 hours, cell survival rate (mitochondrial damage) was measured by MTT assay. The concentration of manganese in cells was measured by AAS, the activity of superoxide dismutase (superoxide dismutase,SOD) by high water-soluble tetrazolium salt (WST-1), and the content of malondialdehyde (malondialdehyde,MDA) by thiobarbituric acid (thibabituric acid,TBA). The levels of dopamine (dopamine,DA), PARK2 mRNA and Parkin were detected by reversed-phase high performance liquid phase (reverse phase high performance liquid chromatography,RP-HPLC) -fluorescence assay, RT-PCR and Western blotting (western blot,WB) respectively. Results: 1Compared with the control group, manganese concentrations in plasma, erythrocyte (red blood cell,RBC, saliva and accumulative manganese exposure in manganese exposure group were 1.7 and 3.0 times higher than those in control group, respectively (P0.05). The expression of PARK2 mRNA in blood of manganese exposure group was decreased by 42% (P0.05). Correlation analysis showed that the expression of PARK2mRNA was negatively correlated with the concentrations of manganese in plasma, RBC, saliva and cumulative manganese exposure. The r values were-0.526 (P0.05), -0.317 (P0.05), -0.652 (P0.05), respectively. -0.737 (P0.05). 2SH-SY5Y cell experiment: compared with the control group, when MnCl_2 concentration was 300500 渭 M, the cell survival rate decreased (P0.05). Compared with the control group, the intracellular manganese concentration in the exposed group was higher than that in the control group (P0.05). Compared with the control group, when MnCl_2 concentration was 300500 渭 M, the activity of SOD and the content of DA decreased (P0.05) (P0.05), and the expression of PARK2 mRNA and Parkin protein decreased (P0.05). Correlation analysis showed that the expression of PARK2 mRNA was negatively correlated with mitochondrial damage, intracellular manganese content and MDA content, r values were -0.902, (P0.05), -0.880 (P0.05), -0.862 (P0.05), respectively. The expression of PARK2 mRNA was positively correlated with the activity of SOD, the content of DA and the expression of Parkin protein (r = 0.879 (P0.05), 0.859 (P0.05), 0.809 (P0.05) respectively). Conclusion: 1 the expression of PARK2 mRNA in blood of workers exposed to manganese decreased, and was negatively correlated with the concentrations of plasma, RBC, saliva and manganese exposed to accumulative manganese. 2 Manganese exposure induced mitochondrial damage and oxidative stress in SH-SY5Y cells. The secretion of DA and the expression of PARK2 decreased.
【學(xué)位授予單位】：遵義醫(yī)學(xué)院
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R114

【相似文獻(xiàn)】

相關(guān)期刊論文 前2條

1 ;Polymorphism analysis of PARK2 gene mutations in Han Chinese patients with early-onset Parkinson's disease[J];Neural Regeneration Research;2010年20期

2 張凌志;;改良Park’s手術(shù)在低位直腸癌中的臨床應(yīng)用[J];中國(guó)醫(yī)療前沿;2009年17期

相關(guān)重要報(bào)紙文章 前8條

1 本報(bào)記者 薛穎旦　江錫民 馬薇 王宏偉;Park經(jīng)濟(jì)：無(wú)錫優(yōu)化發(fā)展的精彩呈現(xiàn)[N];新華日?qǐng)?bào);2009年

2 本報(bào)記者 劉妮麗;751 D·PARK：老工廠上演時(shí)尚秀[N];中國(guó)文化報(bào);2013年

3 本報(bào)記者 伍平;云南銀河T·PARK科技園“首秀”中關(guān)村論壇年會(huì)[N];云南科技報(bào);2013年

4 記者 英潔;Park經(jīng)濟(jì)催生“智慧產(chǎn)業(yè)”高地[N];無(wú)錫日?qǐng)?bào);2009年

5 本版文字 新一　編譯;GiltGroupe推出男士奢侈品零售網(wǎng)站[N];中國(guó)服飾報(bào);2011年

6 顧汶;E-PARK建設(shè)至關(guān)重要[N];中國(guó)高新技術(shù)產(chǎn)業(yè)導(dǎo)報(bào);2004年

7 ;惠山軟件外包園(O—Park)[N];江蘇經(jīng)濟(jì)報(bào);2011年

8 本報(bào)記者 李繼紅;產(chǎn)業(yè)綜合體的云南實(shí)踐[N];云南日?qǐng)?bào);2013年

相關(guān)碩士學(xué)位論文 前6條

1 王慧倩;NPC2蛋白與PARK9 F1區(qū)域蛋白互作研究[D];杭州師范大學(xué);2015年

2 陶冬;RNAi沉默PARK2基因及對(duì)錳致大鼠紋狀體神經(jīng)細(xì)胞PARK2的表達(dá)研究[D];遵義醫(yī)學(xué)院;2014年

3 劉寶;血清S100β、PARK7與急性缺血性腦卒中相關(guān)性研究[D];鄭州大學(xué);2016年

4 范希敏;錳對(duì)人群和SH-SY5Y細(xì)胞中PARK2表達(dá)的影響[D];遵義醫(yī)學(xué)院;2017年

5 夏歡;新疆維吾爾族、漢族帕金森病PARK16基因多態(tài)性研究[D];新疆醫(yī)科大學(xué);2014年

6 王志敏;中風(fēng)病急性期NDKA、NMDA、PARK7、UFDP和痰熱證及NIHSS相關(guān)性研究[D];北京中醫(yī)藥大學(xué);2015年

，

本文編號(hào)：2364486